Global Gene Therapy for Inherited Genetic Disorders Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Eye Disorders
1.2.3 Hematological Disorders
1.2.4 Central Nervous System Disorders
1.2.5 Muscular Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gene Therapy for Inherited Genetic Disorders Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size (2017-2028)
2.2 Gene Therapy for Inherited Genetic Disorders Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Gene Therapy for Inherited Genetic Disorders Market Size by Region (2017-2022)
2.4 Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Region (2023-2028)
2.5 Global Top Gene Therapy for Inherited Genetic Disorders Countries Ranking by Market Size
3 Gene Therapy for Inherited Genetic Disorders Competitive by Company
3.1 Global Gene Therapy for Inherited Genetic Disorders Revenue by Players
3.1.1 Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2017-2022)
3.1.2 Global Gene Therapy for Inherited Genetic Disorders Market Share by Players (2017-2022)
3.2 Global Gene Therapy for Inherited Genetic Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Gene Therapy for Inherited Genetic Disorders Revenue
3.4 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio
3.4.1 Global Gene Therapy for Inherited Genetic Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Inherited Genetic Disorders Revenue in 2021
3.5 Global Gene Therapy for Inherited Genetic Disorders Key Players Head office and Area Served
3.6 Key Players Gene Therapy for Inherited Genetic Disorders Product Solution and Service
3.7 Date of Enter into Gene Therapy for Inherited Genetic Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Gene Therapy for Inherited Genetic Disorders Breakdown Data by Type
4.1 Global Gene Therapy for Inherited Genetic Disorders Historic Revenue by Type (2017-2022)
4.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Revenue by Type (2023-2028)
5 Global Gene Therapy for Inherited Genetic Disorders Breakdown Data by Application
5.1 Global Gene Therapy for Inherited Genetic Disorders Historic Market Size by Application (2017-2022)
5.2 Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022)
6.2 North America Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2028)
6.3 North America Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2028)
6.4 North America Gene Therapy for Inherited Genetic Disorders Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022)
7.2 Europe Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2028)
7.3 Europe Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2028)
7.4 Europe Gene Therapy for Inherited Genetic Disorders Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022)
8.2 Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2028)
8.3 Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2028)
8.4 Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022)
9.2 Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2028)
9.3 Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2028)
9.4 Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022)
10.2 Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2028)
10.3 Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2028)
10.4 Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 BioMarin Pharmaceutical Inc.
11.1.1 BioMarin Pharmaceutical Inc. Company Details
11.1.2 BioMarin Pharmaceutical Inc. Business Overview
11.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Products and Services
11.1.4 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
11.1.5 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders SWOT Analysis
11.1.6 BioMarin Pharmaceutical Inc. Recent Developments
11.2 bluebird bio Inc.
11.2.1 bluebird bio Inc. Company Details
11.2.2 bluebird bio Inc. Business Overview
11.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Products and Services
11.2.4 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
11.2.5 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders SWOT Analysis
11.2.6 bluebird bio Inc. Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Products and Services
11.3.4 Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
11.3.5 Novartis AG Gene Therapy for Inherited Genetic Disorders SWOT Analysis
11.3.6 Novartis AG Recent Developments
11.4 Orchard Therapeutics Plc
11.4.1 Orchard Therapeutics Plc Company Details
11.4.2 Orchard Therapeutics Plc Business Overview
11.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Products and Services
11.4.4 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
11.4.5 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders SWOT Analysis
11.4.6 Orchard Therapeutics Plc Recent Developments
11.5 Spark Therapeutics Inc.
11.5.1 Spark Therapeutics Inc. Company Details
11.5.2 Spark Therapeutics Inc. Business Overview
11.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Products and Services
11.5.4 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
11.5.5 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders SWOT Analysis
11.5.6 Spark Therapeutics Inc. Recent Developments
12 Gene Therapy for Inherited Genetic Disorders Market Dynamics
12.1 Gene Therapy for Inherited Genetic Disorders Market Trends
12.2 Gene Therapy for Inherited Genetic Disorders Market Drivers
12.3 Gene Therapy for Inherited Genetic Disorders Market Challenges
12.4 Gene Therapy for Inherited Genetic Disorders Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Eye Disorders
Table 3. Key Players of Hematological Disorders
Table 4. Key Players of Central Nervous System Disorders
Table 5. Key Players of Muscular Disorders
Table 6. Key Players of Others
Table 7. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Gene Therapy for Inherited Genetic Disorders Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Gene Therapy for Inherited Genetic Disorders Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Region (2017-2022)
Table 11. Global Gene Therapy for Inherited Genetic Disorders Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Gene Therapy for Inherited Genetic Disorders Market Share by Players (2017-2022)
Table 13. Global Top Gene Therapy for Inherited Genetic Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2021)
Table 14. Ranking of Global Top Gene Therapy for Inherited Genetic Disorders Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Gene Therapy for Inherited Genetic Disorders Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Gene Therapy for Inherited Genetic Disorders Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2017-2022)
Table 22. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2023-2028)
Table 24. Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2017-2022)
Table 26. Global Gene Therapy for Inherited Genetic Disorders Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2023-2028)
Table 28. North America Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Gene Therapy for Inherited Genetic Disorders Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America Gene Therapy for Inherited Genetic Disorders Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America Gene Therapy for Inherited Genetic Disorders Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Gene Therapy for Inherited Genetic Disorders Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Gene Therapy for Inherited Genetic Disorders Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe Gene Therapy for Inherited Genetic Disorders Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe Gene Therapy for Inherited Genetic Disorders Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Gene Therapy for Inherited Genetic Disorders Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Gene Therapy for Inherited Genetic Disorders Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue by Country (2023-2028) & (US$ Million)
Table 63. BioMarin Pharmaceutical Inc. Company Details
Table 64. BioMarin Pharmaceutical Inc. Business Overview
Table 65. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product and Services
Table 66. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022) & (US$ Million)
Table 67. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders SWOT Analysis
Table 68. BioMarin Pharmaceutical Inc. Recent Developments
Table 69. bluebird bio Inc. Company Details
Table 70. bluebird bio Inc. Business Overview
Table 71. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product and Services
Table 72. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022) & (US$ Million)
Table 73. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders SWOT Analysis
Table 74. bluebird bio Inc. Recent Developments
Table 75. Novartis AG Company Details
Table 76. Novartis AG Business Overview
Table 77. Novartis AG Gene Therapy for Inherited Genetic Disorders Product and Services
Table 78. Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022) & (US$ Million)
Table 79. Novartis AG Gene Therapy for Inherited Genetic Disorders SWOT Analysis
Table 80. Novartis AG Recent Developments
Table 81. Orchard Therapeutics Plc Company Details
Table 82. Orchard Therapeutics Plc Business Overview
Table 83. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product and Services
Table 84. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022) & (US$ Million)
Table 85. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders SWOT Analysis
Table 86. Orchard Therapeutics Plc Recent Developments
Table 87. Spark Therapeutics Inc. Company Details
Table 88. Spark Therapeutics Inc. Business Overview
Table 89. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product and Services
Table 90. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue in Gene Therapy for Inherited Genetic Disorders Business (2017-2022) & (US$ Million)
Table 91. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders SWOT Analysis
Table 92. Spark Therapeutics Inc. Recent Developments
Table 93. Gene Therapy for Inherited Genetic Disorders Market Trends
Table 94. Gene Therapy for Inherited Genetic Disorders Market Drivers
Table 95. Gene Therapy for Inherited Genetic Disorders Market Challenges
Table 96. Gene Therapy for Inherited Genetic Disorders Market Restraints
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Gene Therapy for Inherited Genetic Disorders Sales Market Share by Type: 2021 VS 2028
Figure 2. Eye Disorders Features
Figure 3. Hematological Disorders Features
Figure 4. Central Nervous System Disorders Features
Figure 5. Muscular Disorders Features
Figure 6. Others Features
Figure 7. Global Gene Therapy for Inherited Genetic Disorders Sales Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Others Case Studies
Figure 12. Gene Therapy for Inherited Genetic Disorders Report Years Considered
Figure 13. Global Gene Therapy for Inherited Genetic Disorders Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Gene Therapy for Inherited Genetic Disorders Market Size 2017-2028 (US$ Million)
Figure 15. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Gene Therapy for Inherited Genetic Disorders Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Gene Therapy for Inherited Genetic Disorders Market Share by Players in 2021
Figure 19. Global Top Gene Therapy for Inherited Genetic Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Inherited Genetic Disorders as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue in 2021
Figure 21. North America Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Company in 2021
Figure 22. North America Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2017-2028)
Figure 23. North America Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2017-2028)
Figure 24. North America Gene Therapy for Inherited Genetic Disorders Revenue Share by Country (2017-2028)
Figure 25. U.S. Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Company in 2021
Figure 28. Europe Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2017-2028)
Figure 29. Europe Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2017-2028)
Figure 30. Europe Gene Therapy for Inherited Genetic Disorders Revenue Share by Country (2017-2028)
Figure 31. Germany Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 32. France Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Gene Therapy for Inherited Genetic Disorders Revenue Share by Region (2017-2028)
Figure 40. China Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 43. India Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 49. Philippines Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 50. Vietnam Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 51. Latin America Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Company in 2021
Figure 52. Latin America Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2017-2028)
Figure 54. Latin America Gene Therapy for Inherited Genetic Disorders Revenue Share by Country (2017-2028)
Figure 55. Mexico Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 56. Brazil Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 57. Argentina Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 58. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Company in 2021
Figure 59. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Type (2017-2028)
Figure 60. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Revenue Share by Country (2017-2028)
Figure 62. Turkey Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 63. Saudi Arabia Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 64. U.A.E Gene Therapy for Inherited Genetic Disorders Revenue (2017-2028) & (US$ Million)
Figure 65. BioMarin Pharmaceutical Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
Figure 66. bluebird bio Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
Figure 67. Novartis AG Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
Figure 68. Orchard Therapeutics Plc Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
Figure 69. Spark Therapeutics Inc. Revenue Growth Rate in Gene Therapy for Inherited Genetic Disorders Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed